Finance

Beta
Lists
ONCO3:BVMF
Oncoclinicas do Brasil Srvcs Mdcs SA
R$1.20
-8.40%
(-0.11) 1D
May 29, 1:33:51 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for ONCO3...
Open
R$1.31
High
R$1.39
Low
R$1.12
Mkt. cap
1.35B
Avg. vol.
8.04M
Volume
9.31M
52-wk high
R$5.77
52-wk low
R$0.99
EPS
-R$5.09
Shares outstanding
1.14B
Open
R$1.31
High
R$1.39
Low
R$1.12
Mkt. cap
1.35B
Avg. vol.
8.04M
Volume
9.31M
52-wk high
R$5.77
52-wk low
R$0.99
EPS
-R$5.09
Shares outstanding
1.14B
News stories
From sources across the web
About Oncoclinicas do Brasil Srvcs Mdcs SA
CEOBruno Lemos Ferrari
Employees-
Founded2010
Headquarters-
SectorHealth care provider
Websitegrupooncoclinicas.com
Last report
May 15, 2026
Fiscal period
Q1 2026
EPS / Est. (BRL)
- / -R$0.01
Revenue / Est. (BRL)
1.16B / 1.38B
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in BRL
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.46B
1.41B
1.37B
1.16B
Cost of goods sold
1.02B
959.85M
887.92M
961.32M
Cost of revenue
1.02B
959.85M
887.92M
961.32M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
352.32M
283.58M
366.58M
313.07M
Operating expense
378.46M
1.89B
514.52M
481.09M
Total operating expenses
1.40B
2.85B
1.40B
1.44B
Operating income
61.55M
-1.43B
-33.61M
-281.64M
Other non operating income
-52.62M
-9.60M
-568.93M
28.27M
EBT including unusual items
-129.68M
-1.85B
-1.09B
-436.10M
EBT excluding unusual items
-124.68M
-1.63B
-606.65M
-436.10M
Income tax expense
12.61M
26.67M
429.22M
2.56M
Effective tax rate
-9.72%
-1.44%
-39.49%
-0.59%
Other operating expenses
26.14M
1.60B
147.94M
168.02M
Net income
-140.99M
-1.88B
-1.45B
-364.20M
Net profit margin
-9.63%
-133.22%
-106.22%
-31.38%
Earnings per share
-
-0.15
-
-
Interest and investment income
41.66M
44.65M
1.45M
-
Interest expense
-163.16M
-230.76M
-6.99M
-185.39M
Net interest expenses
-121.50M
-186.11M
-5.54M
-185.39M
Depreciation and amortization charges
-
-
-
-
EBITDA
101.34M
-1.39B
13.39M
-209.10M
Gain or loss from assets sale
-
466.21M
-31.88M
-11.81M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer